Format
Items per page
Sort by

Send to:

Choose Destination

Results: 16

Related Articles by Review for PubMed (Select 19594447)

1.

Bioluminescent CXCL12 fusion protein for cellular studies of CXCR4 and CXCR7.

Luker K, Gupta M, Luker G.

Biotechniques. 2009 Jul;47(1):625-32. doi: 10.2144/000113126.

2.

The peculiarities of the SDF-1/CXCL12 system: in some cells, CXCR4 and CXCR7 sing solos, in others, they sing duets.

Puchert M, Engele J.

Cell Tissue Res. 2014 Feb;355(2):239-53. doi: 10.1007/s00441-013-1747-y. Epub 2013 Nov 29. Review.

PMID:
24292718
3.

Chemokine receptor trio: CXCR3, CXCR4 and CXCR7 crosstalk via CXCL11 and CXCL12.

Singh AK, Arya RK, Trivedi AK, Sanyal S, Baral R, Dormond O, Briscoe DM, Datta D.

Cytokine Growth Factor Rev. 2013 Feb;24(1):41-9. doi: 10.1016/j.cytogfr.2012.08.007. Epub 2012 Sep 16. Review.

4.

CXCL12 / CXCR4 / CXCR7 chemokine axis and cancer progression.

Sun X, Cheng G, Hao M, Zheng J, Zhou X, Zhang J, Taichman RS, Pienta KJ, Wang J.

Cancer Metastasis Rev. 2010 Dec;29(4):709-22. doi: 10.1007/s10555-010-9256-x. Review. Erratum in: Cancer Metastasis Rev. 2011 Jun;30(2):269-70.

5.

Involvement of CXCR4/CXCR7/CXCL12 Interactions in Inflammatory bowel disease.

Werner L, Guzner-Gur H, Dotan I.

Theranostics. 2013;3(1):40-6. doi: 10.7150/thno.5135. Epub 2013 Jan 15. Review.

6.

The role of the CXCL12-CXCR4/CXCR7 axis in the progression and metastasis of bone sarcomas (Review).

Liao YX, Zhou CH, Zeng H, Zuo DQ, Wang ZY, Yin F, Hua YQ, Cai ZD.

Int J Mol Med. 2013 Dec;32(6):1239-46. doi: 10.3892/ijmm.2013.1521. Epub 2013 Oct 11. Review.

PMID:
24127013
7.

The relevance of the chemokine receptor ACKR3/CXCR7 on CXCL12-mediated effects in cancers with a focus on virus-related cancers.

Freitas C, Desnoyer A, Meuris F, Bachelerie F, Balabanian K, Machelon V.

Cytokine Growth Factor Rev. 2014 Jun;25(3):307-16. doi: 10.1016/j.cytogfr.2014.04.006. Epub 2014 May 9. Review.

PMID:
24853339
8.

An infernal trio: the chemokine CXCL12 and its receptors CXCR4 and CXCR7 in tumor biology.

Hattermann K, Mentlein R.

Ann Anat. 2013 Mar;195(2):103-10. doi: 10.1016/j.aanat.2012.10.013. Epub 2012 Dec 8. Review.

PMID:
23279723
9.

CXCR7 impact on CXCL12 biology and disease.

Sánchez-Martín L, Sánchez-Mateos P, Cabañas C.

Trends Mol Med. 2013 Jan;19(1):12-22. doi: 10.1016/j.molmed.2012.10.004. Epub 2012 Nov 12. Review.

PMID:
23153575
10.

CXCL12 (SDF1alpha)-CXCR4/CXCR7 pathway inhibition: an emerging sensitizer for anticancer therapies?

Duda DG, Kozin SV, Kirkpatrick ND, Xu L, Fukumura D, Jain RK.

Clin Cancer Res. 2011 Apr 15;17(8):2074-80. doi: 10.1158/1078-0432.CCR-10-2636. Epub 2011 Feb 24. Review.

11.

The role of stromal-derived factor-1--CXCR7 axis in development and cancer.

Maksym RB, Tarnowski M, Grymula K, Tarnowska J, Wysoczynski M, Liu R, Czerny B, Ratajczak J, Kucia M, Ratajczak MZ.

Eur J Pharmacol. 2009 Dec 25;625(1-3):31-40. doi: 10.1016/j.ejphar.2009.04.071. Epub 2009 Oct 14. Review.

12.

CXCR7, CXCR4 and CXCL12: an eccentric trio?

Thelen M, Thelen S.

J Neuroimmunol. 2008 Jul 31;198(1-2):9-13. doi: 10.1016/j.jneuroim.2008.04.020. Epub 2008 Jun 3. Review.

PMID:
18533280
13.

CXCR4/CXCR7 molecular involvement in neuronal and neural progenitor migration: focus in CNS repair.

Merino JJ, Bellver-Landete V, Oset-Gasque MJ, Cubelos B.

J Cell Physiol. 2015 Jan;230(1):27-42. doi: 10.1002/jcp.24695. Review.

PMID:
24913264
14.

CXCR4: a virus's best friend?

Arnolds KL, Spencer JV.

Infect Genet Evol. 2014 Jul;25:146-56. doi: 10.1016/j.meegid.2014.04.018. Epub 2014 May 2. Review.

15.

Functions of the chemokine receptor CXCR4 in the central nervous system and its regulation by μ-opioid receptors.

Nash B, Meucci O.

Int Rev Neurobiol. 2014;118:105-28. doi: 10.1016/B978-0-12-801284-0.00005-1. Review.

16.

Split-luciferase complementary assay: applications, recent developments, and future perspectives.

Azad T, Tashakor A, Hosseinkhani S.

Anal Bioanal Chem. 2014 Sep;406(23):5541-60. doi: 10.1007/s00216-014-7980-8. Epub 2014 Jul 8. Review.

PMID:
25002334
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk